1. Home
  2. Labeler Index
  3. Blenheim Pharmacal, Inc.
  4. 10544-436
  5. Product Images: Gabapentin

Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 10544-436 by Blenheim Pharmacal, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structure - a58e76e8 0645 4c40 a738 5015e88bd68c 01

structure - a58e76e8 0645 4c40 a738 5015e88bd68c 01

Figure 1 - a58e76e8 0645 4c40 a738 5015e88bd68c 02

Figure 1 - a58e76e8 0645 4c40 a738 5015e88bd68c 02

This is a chart showing the Mean Pain Score over a 4-week Dose Titration Period and 4-week Fixed Dose Period, with Placebo and Gabapentin at 3600 mg/day. The chart includes Baseline and 8 weeks.*

Figure 2 - a58e76e8 0645 4c40 a738 5015e88bd68c 03

Figure 2 - a58e76e8 0645 4c40 a738 5015e88bd68c 03

This is a graph showing the mean pain score for a study with a 3-week dose titration period and a 4-week fixed dose period. The study included a placebo group and two groups taking different doses of Gabapentin. The x-axis shows the weeks of the study and the y-axis shows the mean pain score.*

Figure 3 - a58e76e8 0645 4c40 a738 5015e88bd68c 04

Figure 3 - a58e76e8 0645 4c40 a738 5015e88bd68c 04

The text seems to be presenting data related to a clinical trial study (Study 1) and shows the percentage of responders at some endpoint. The data is presented in a table/chart format with percentages ranging from 10% to 50+. The significance values of the results are also mentioned with the text "* p<0.01" and "5% p <0,001". Furthermore, there is a mention of 254 participants involved in the study.*

Figure 4 - a58e76e8 0645 4c40 a738 5015e88bd68c 05

Figure 4 - a58e76e8 0645 4c40 a738 5015e88bd68c 05

Label Graphic-Gabapentin (Blenheim) 300mg 90s - a58e76e8 0645 4c40 a738 5015e88bd68c 06

Label Graphic-Gabapentin (Blenheim) 300mg 90s - a58e76e8 0645 4c40 a738 5015e88bd68c 06

This is a description of Gabapentin capsules marked with NDC number 10544-436-90 and LCN number 000. The capsules are manufactured by Apotex Corp with a dosage strength of 300mg. There are 90 capsules in each pack that are only available with a prescription from a certified physician. The capsules should be stored in a container that is tight and light-resistant, and kept out of reach of children. The lot number for the capsules is BPO00O000D, and the expiry date is 00/00/0000. There is additional information about other Gabapentin capsules in varying quantities with lot numbers and expiry dates.*

Label Graphic-Gabapentin (Blenheim) 400mg 90s - a58e76e8 0645 4c40 a738 5015e88bd68c 07

Label Graphic-Gabapentin (Blenheim) 400mg 90s - a58e76e8 0645 4c40 a738 5015e88bd68c 07

Gabapentin Capsules, USP 400mg, in a package of 90 capsules, with the NDC code 10544-447-90 and LCN# oo0, manufactured by Apotex Corp. and with a lot number BPODOOODOO, is a prescription medicine. The dosage is not available due to a damaged package but a suitable temperature is advised. The medication is permitted to be stored at temperatures of up to 150 0% aGE B. This medication is indicated for the treatment of certain types of seizures and neuropathic pain. The expiration date of the product is 00/00/0000.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.